Cardiovascular Effects of Partial Sleep Deprivation
Background: Sleep curtailment is common and is associated with increased mortality due to cardiovascular causes. However, the mechanisms are not completely understood.We hypothesized that partial sleep deprivation caused however significant changes in sympathetic activity and endothelial function in healthy volunteers.
Methods: Thirteen young healthy male volunteers will be monitored during 12 days by sleep diary and wrist actigraphy. The subjects will keep under their usual daily activities and randomized to 5 nights of prolonged sleep (control) or partial sleep deprivation, interposed by 2 nights of unrestricted sleep (wash out). At the end of each period, the subjects will be evaluate by: 1. electrocardiogram and beat-to-beat blood pressure with spectral analysis of heart rate and blood pressure in the supine position and after head up tilt test maneuver; 2. resting plasma norepinephrine; 3. venous endothelial function (dorsal hand vein technique).
Volunteers Healthy young male volunteers from the urban area of Sao Paulo city will be recruited to the study. All subjects will be clinically evaluated, including measurements of weight and height. Exclusion criteria include age less than 21 and more than 45 years, body mass index (BMI) >25 kg/m2, smoking, use of chronic medications and any established medical condition including diabetes mellitus, hypertension, dyslipidemia, heart diseases and sleep disordered breathing. After obtaining written informed consent, all participants will be submitted to overnight polysomnography.
Polysomnography Overnight polysomnography will be performed to discarded sleep breathing using a digital system (17 channels, EMBLA Medicare - Flaga hf. Medical Devices). All polysomnograms will be performed and scored based on the guidelines for sleep studies. The apnea-hypopnoea index (AHI) was defined by the number of apneas and hypopnoeas per hour of sleep. Sleep disordered breathing was defined by an AHI above 5 events/hour, according to standard criteria.
Sleep Monitoring During the study period all subjects will be continuously monitored by a sleep diary and wrist actigraphy (Basic Mini Motionlogger Actigraph Ambulatory Monitoring, Inc., Ardsley , New York, USA ) worn on the non-dominant hand. The actigraph will set to sample movements in 1 min periods. Actigraph records will automatically process by use of the AW2 software version 2.3.01 program (Ambulatory Monitoring, Inc.) to extract information on sleep duration.
Blood Samples Venous blood will be collected from all participants between 8 and 10 AM for the measurement of glucose, total cholesterol, low-density lipoprotein, high-density lipoprotein, and red blood cell count. Plasma catecholamine (norepinephrine) will be measured by High-Performance Liquid Chromatography.
Hemodynamic and autonomic measurements Hemodynamic and autonomic evaluations will be performed in the morning between 8 and 10 AM. The intervals between adjacent QRS complexes resulting from sinus node depolarization will be determined (RR intervals). Heart rate will be calculated by expressing RR intervals as beats per minute. Non-invasive beat-to-beat blood pressure (Finometer, Finapres Medical System BV, Holland) and electrocardiogram (ECG) will be continuously recorded by the software AT/MCA-CODAS (DATAC Instruments Inc., Akron, Ohio, EUA). The sampling rate was 1000 Hz per channel.
Autonomic measurements will be derived from spectral analysis of HR and systolic blood pressure (SBP). For frequency domain analysis, power spectral density will be obtained by the Fast Fourier Transformation using the Welch's method over 16,384 points with a Hanning window (512) and 50% overlapping. Spectral power for low- (LF 0.04-0.15 Hz), and high- (HF 0.15-0.4 Hz) frequency bands will be calculated by means of power spectrum density integration within each frequency bandwidth, using a customized routine (MATLAB 6.0, Mathworks). LF/HF ratio will be also calculated to evaluate the sympathovagal balance. In addition, we will also evaluated the power spectral analysis of SBP.
The measurements will be evaluated while awake in supine position (5 minutes) and subsequently during head up tilt test maneuver (60 degree inclination, 5 minutes). The results of tilt test will be expressed as the change between rest and head up tilt .
Endothelial function Venous endothelial function will be measured by Dorsal Hand Vein technique, previously described by Aellig.
Briefly, a 23-gauge butterfly needle will be inserted into a suitable vein on the back of the hand, with the arm positioned at an upward angle of 30 to allow the complete emptying of veins. A tripod, holding a linear variable differential transformer (LVDT) (Shaevitz Engineering, Pennsuaken, NJ), will be mounted on the back of the hand with the central aperture of the LVDT, containing a movable metal core, at a distance of 10 mm downstream from the dip of the needle. The signal output of the LVDT, which will be linearly proportional to the vertical movement of the core, give a measure of the diameter of the vein. Readings will be taken under a congestive pressure of 40 mm Hg by inflating a blood pressure cuff placed on the upper portion of the arm under study. Results will be presented as normalized dose-response curves in which the diameter of the vein during saline infusion will be defined as 100% dilatation. The vein will be preconstricted to 20% of the baseline size by infusing increasing doses of phenylephrine, a selective A-adrenergic receptor agonist (25-3166 ng/min). The infusion rate of phenylephrine inducing 80% venoconstriction will be kept constant during the entire study, rate, and this degree of constriction will be defined as 0% dilatation for the purpose of subsequent calculations. The vasodilator response expressed in this study will be calculated as a percentage of the range between 0 and 100% dilatation. Drugs will be infused using a Harvard infusion pump (Harvard Apparatus, South Natick, MA) at a flow rate of 0.3 ml/min. After preconstriction of the vein by using phenylephrine, a dose-response curve of acetylcholine (0.36-3600 ng/min) and sodium nitroprusside (50-1000 ng/min) will be constructed with 6 and 2 infusion doses, respectively. Systolic and diastolic BP will be determined before and after each experimental phase with a mercury sphygmomanometer, and heart rate will be measured by the pulse at the radial artery.
Experimental Design The entire study period will be of 12 nights. Using a cross over design the subjects will keep under their usual daily activities and randomized to 5 nights of control sleep or partial sleep deprivation, interposed by 2 nights of wash out (unrestricted sleep). During control period, subjects will be instructed to sleep 8 hours, ranging from a minimal of 7 hours and a maximum of 9 hours and 30 minutes. Partial sleep deprivation will consist of a target sleep between of less than 5 hours, but no less than 3 hours and 30 minutes. Subjects who will not comply with the sleep schedule will be excluded from the final analysis. All measurements described above will be made at the end of control and partial sleep deprivation periods.
Allocation: Randomized, Control: Active Control, Intervention Model: Crossover Assignment, Masking: Open Label
Partial sleep deprivation
Heart Institute (InCor)
University of Sao Paulo
Results (where available)
- Source: http://clinicaltrials.gov/show/NCT00669513
- Information obtained from ClinicalTrials.gov on July 15, 2010
The aim of the study is to determine the impact of aging, circadian rhythms and sleep deprivation on executive performances. Volunteers will complete a 40-hour extended wakefulness period ...
40 patients with the diagnosis of major depression are included. There are two interventions: partial sleep deprivation (PSD) and normal night sleep (CTRL). Patients are randomly assigned ...
This study evaluates the efficacy of sleep deprivation treatment in accelerating antidepressant responses when administered during the first week of medications and augmenting a sustained ...
The aims of this study are examine the effects of sleep deprivation in muscle recovery after a maximum eccentric resistance exercise session performed on an isokinetic dynamometer (24 seri...
The purpose of this study is to determine whether or not a low calorie, low glycemic index diet with omega-3 fatty acid supplements can prevent some of the negative consequences of sleep d...
Inflammatory bowel disease is a chronic inflammatory condition of the gastrointestinal tract. It can be aggravated by stress, like sleep deprivation, and improved by anti-inflammatory agents, like mel...
There are few studies examining changes in waking function in a laboratory environment with no sleep deprivation and mood has been largely overlooked in this context. The present study examined change...
Sleep deprivation and obesity, are associated with neurocognitive impairments. Effects of sleep deprivation and obesity on cognition are unknown, and the cognitive long-term effects of improvement of ...
Sleep loss is suspected to induce endothelial dysfunction, a key factor in cardiovascular risk. We examined whether sympathetic activity is involved in the endothelial dysfunction caused by total slee...
Sleep Posters IISESSION TYPE: Original Investigation PosterPRESENTED ON: Wednesday, October 29, 2014 at 01:30 PM - 02:30 PMPURPOSE: In hospitalized patients, sleep deprivation potentially leads to neg...
Medical and Biotech [MESH] Definitions
The state of being deprived of sleep under experimental conditions, due to life events, or from a wide variety of pathophysiologic causes such as medication effect, chronic illness, psychiatric illness, or sleep disorder.
A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395)
Movements or behaviors associated with sleep, sleep stages, or partial arousals from sleep that may impair sleep maintenance. Parasomnias are generally divided into four groups: arousal disorders, sleep-wake transition disorders, parasomnias of REM sleep, and nonspecific parasomnias. (From Thorpy, Sleep Disorders Medicine, 1994, p191)
Excessive periodic leg movements during sleep that cause micro-arousals and interfere with the maintenance of sleep. This condition induces a state of relative sleep deprivation which manifests as excessive daytime hypersomnolence. The movements are characterized by repetitive contractions of the tibialis anterior muscle, extension of the toe, and intermittent flexion of the hip, knee and ankle. (Adams et al., Principles of Neurology, 6th ed, p387)
Periods of sleep manifested by changes in EEG activity and certain behavioral correlates; includes Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep.